Tag: Pharmaceuticals
Business & Industry
Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition
Neurocrine Biosciences is close to securing a more than $2.5bn acquisition of Soleno Therapeutics, the developer of a treatment for a rare genetic form...
Business & Industry
Biogen to Acquire Apellis for $5.6 Billion in Major Deal
Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, in a move that significantly expands its presence in immunology and rare...
Articles
The Evolution of Field Execution in Specialty Pharma: From Coverage to Engagement
Why Field Execution Must Evolve
Field execution — how pharma companies organize, direct, and deliver commercial and medical interactions with healthcare professionals (HCPs), prescribers, and...
Business & Industry
Trump Announces 100% US Pharma Tariffs for Patented Drugs
The US pharma tariffs policy has been formalised through an executive order signed by Donald Trump, introducing tariffs of up to 100% on imported...
Business & Industry
UK-US Pharma Trade Deal Drives Tariff Cuts, Pricing Shift
Britain has finalised a UK-US pharma trade deal, securing tariff-free access for UK-made medicines to the United States while committing to higher domestic spending...
Business & Industry
Eli Lilly to Acquire Centessa Pharmaceuticals in $7.8B Deal
Eli Lilly & Co. is set to acquire Centessa Pharmaceuticals Plc in a transaction worth up to $7.8 billion, underscoring its push to broaden...
Business & Industry
Novartis $2bn Excellergy Acquisition Boosts Allergy Pipeline
Novartis has entered into an agreement to acquire biotech firm Excellergy, a move that will bring a next-generation anti-immunoglobulin e (IgE) programme into its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read